Shire Announces Results Of The Tender Offer For Movetis NV And Commencement Of Squeeze-Out Tender Period
DUBLIN, September 30, 2010 /PRNewswire/ -- Shire plc , the global specialty biopharmaceutical company, announces that shareholders of Movetis NV have tendered 99.18% of the shares of Movetis during…